General

RÉSULTAT DE L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE LA SOCIÉTÉ ÉTABLISSEMENTS FAUVET-GIREL, INITIÉE PAR ADVANCED BIOLOGICAL LABORATORIES S.A

L’offre publique d’achat simplifiée visant les actions ETABLISSEMENTS FAUVET-GIREL, initiée le23 décembre 2021 par ADVANCED BIOLOGICAL LABORATORIES SA (« ABL SA »), s’est clôturée le 7 janvier 2022. A l’occasion de cette offre, ABL SA a acquis 954 actions représentant 0,38% du capital et 0,38% des droits de vote de la société ETABLISSEMENTS FAUVET-GIREL. À la clôture de

RÉSULTAT DE L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE LA SOCIÉTÉ ÉTABLISSEMENTS FAUVET-GIREL, INITIÉE PAR ADVANCED BIOLOGICAL LABORATORIES S.A Read More »

ABL Announces Distribution Agreement with Hayleys Lifesciences in Sri Lanka

Advanced Biological Laboratories (ABL) S.A. and Hayleys Lifesciences  are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Sri Lanka. See all the current Distributors ABL DIAGNOSTICS S.A. 42, rue Olivier Métra – Bat E1 75020, PARIS FRANCE Phone :

ABL Announces Distribution Agreement with Hayleys Lifesciences in Sri Lanka Read More »

The Luxembourg Institute of Health and Advanced Biological Laboratories develop joint Diagnostic Solutions to measure neutralizing antibodies against Sars CoV-2 variants

The Luxembourg Institute of Health (LIH) and Advanced Biological Laboratories (ABL) are joining forces to predict immune protection against COVID-19 and support long-term vaccination strategies. To this end, the two laboratories have signed a license agreement and a collaboration agreement to provide two in vitro diagnostic solutions to measure neutralizing antibody levels.   LIH has established a

The Luxembourg Institute of Health and Advanced Biological Laboratories develop joint Diagnostic Solutions to measure neutralizing antibodies against Sars CoV-2 variants Read More »

ABL ANNOUNCES DISTRIBUTION AGREEMENT WITH MEDSOL IN SAUDI ARABIA

ABL announces Distribution Agreement with Medsol in Saudi Arabia Advanced Biological Laboratories (ABL) S.A. and Medsol Corporation  are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Saudi Arabia. See current channel partners. Find us on: ABL DIAGNOSTICS   42,

ABL ANNOUNCES DISTRIBUTION AGREEMENT WITH MEDSOL IN SAUDI ARABIA Read More »

Scroll to Top